The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Richard J. Epstein

Medical Oncology Unit

Department of Medicine

The University of Hong Kong

Queen Mary Hospital

Hong Kong

[email]@hku.hk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Medical Oncology Unit, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong. 2004 - 2009
  • Division of Haematology and Oncology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, China. 2008 - 2009
  • Division of Haematology/Oncology, Room 802, Administrative Block, Department of Medicine, Hong Kong. 2008

References

  1. Visual impairment in myopic patients with breast cancer receiving adjuvant therapy with aromatase inhibitors. Epstein, R.J. Clin. Breast Cancer (2009) [Pubmed]
  2. The threat that dare not speak its name: human extinction. Epstein, R.J., Zhao, Y. Perspect. Biol. Med. (2009) [Pubmed]
  3. TNM: therapeutically not mandatory. Epstein, R.J. Eur. J. Cancer (2009) [Pubmed]
  4. Tumor resensitization to erlotinib following brief substitution of cetuximab. Epstein, R.J., Leung, T.W. Cancer Chemother. Pharmacol. (2008) [Pubmed]
  5. Loading doses for costly cancer biologicals: sound pharmacology or unnecessary extravagance?. Epstein, R.J., Cheung, B.M. Eur. J. Cancer (2008) [Pubmed]
  6. VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic. Epstein, R.J. Cancer Metastasis Rev. (2007) [Pubmed]
  7. Reversing hepatocellular carcinoma progression by using networked biological therapies. Epstein, R.J., Leung, T.W. Clin. Cancer Res. (2007) [Pubmed]
  8. Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care. Epstein, R.J. BMC. Cancer (2007) [Pubmed]
  9. Growth of the Asian health-care market: global implications for the pharmaceutical industry. Epstein, R.J. Nat. Rev. Drug. Discov (2007) [Pubmed]
  10. Utility of a web-based breast cancer predictive algorithm for adjuvant chemotherapeutic decision making in a multidisciplinary oncology center. Epstein, R.J., Leung, T.W., Mak, J., Cheung, P.S. Cancer Invest. (2006) [Pubmed]
  11. Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment. Epstein, R.J. Clin. Cancer Res. (2005) [Pubmed]
  12. "Leaving town" versus "taking leave": the case for re-thinking academic leave restrictions. Epstein, R.J. Postgrad. Med. J (2005) [Pubmed]
  13. Learning from the problems of problem-based learning. Epstein, R.J. BMC. Med. Educ (2004) [Pubmed]
  14. The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies. Epstein, R.J. Nat. Rev. Cancer (2004) [Pubmed]
  15. Journal impact factors do not equitably reflect academic staff performance in different medical subspecialties. Epstein, R.J. J. Investig. Med. (2004) [Pubmed]
 
WikiGenes - Universities